Source: International Congress 2017 – Rare diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Matsuzaki (Tokyo, Japan). Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases. 3855

Member's Comments

No comment yet.

Related content which might interest you: Causes of chronic cough in patients with interstitial pneumonia Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008 Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Bronchopulmonary infections cause exacerbation of chronic obstructive pulmonary diseases in the ICU Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002 Acute exacerbations of progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018 Year: 2018 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Chronic suppurative lung disease as a cause of ‘difficult asthma‘ in paediatric patients Source: Eur Respir J 2005; 26: Suppl. 49, 166s Year: 2005 The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 A study on the pulmonary function of patients with chronic eosinophilic pneumonia Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017